Oral contraceptives and venous thromboembolism. New Zealand Committee, RANZCOG. Royal Australian and New Zealand College of Obstetricians and Gynaecologists

No authors listed

Comment

No authors listed. N Z Med J. 2000.

. 2000 May 26;113(1110):196.

No abstract available

Comment in

Oral contraceptives and venous thromboembolism.
Skegg D. Skegg D. N Z Med J. 2000 Sep 8;113(1117):385. N Z Med J. 2000. PMID: 11050907 No abstract available.

Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertainty.
Maling TJ. Maling TJ. N Z Med J. 1999 Aug 27;112(1094):305-7. N Z Med J. 1999. PMID: 10493438 Review. No abstract available.

Incidence of venous thromboembolism in users of combined oral contraceptives. Risk is particularly high with first use of oral contraceptives.
Vandenbrouke JP, Bloemenkamp KW, Rosendaal FR, Helmerhorst FM. Vandenbrouke JP, et al. BMJ. 2000 Jan 1;320(7226):57-8. BMJ. 2000. PMID: 10671043 No abstract available.
Incidence of venous thromboembolism in users of combined oral contraceptives. Methods for identifying cases and estimating person time at risk must be detailed.
Jick H. Jick H. BMJ. 2000 Jan 1;320(7226):57; author reply 57-8. BMJ. 2000. PMID: 10617543 Free PMC article. No abstract available.
What is the risk of venous thromboembolism (VTE) among women taking third-generation oral contraceptives (OCs) in comparison with those taking contraceptives containing levonorgestrel?
Meurer LN, Slawson JG. Meurer LN, et al. J Fam Pract. 2001 Feb;50(2):108. J Fam Pract. 2001. PMID: 11219554 No abstract available.
The truth about oral contraceptives and venous thromboembolism.
Shulman LP, Goldzieher JW. Shulman LP, et al. J Reprod Med. 2003 Nov;48(11 Suppl):930-8. J Reprod Med. 2003. PMID: 14686030 Review.
Third generation oral contraceptives and the risk of venous thromboembolism: management of the uncertainty.
Maling TJ. Maling TJ. N Z Med J. 1999 Aug 27;112(1094):305-7. N Z Med J. 1999. PMID: 10493438 Review. No abstract available.